Danish pharmaceutical company Novo Nordisk is expanding its global partnership with UNICEF to prevent overweight and obesity among children. Novo is investing USD 18 million in 2026-2030.
The program runs from 2027 to 2030 and will reach more than 80 million children in Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya.
Measures include dietary advice, physical activity, health check-ups and preventive measures.
